# EPINEX DIAGNOSTICS INC: Form D filings

EPINEX DIAGNOSTICS INC, a biotechnology company in Tustin, CA, filed 13 Form D notices with the SEC between 2009 and 2016. The latest, on February 10, 2016, reports $100,000 sold of a $100,000 offering to 1 investor.

Find out what EPINEX DIAGNOSTICS INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20EPINEX%20DIAGNOSTICS%20INC%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=EPINEX%20DIAGNOSTICS%20INC&page=%2Fdata%2Fform-d%2Fcompany%2Fepinex-diagnostics-inc-1309623)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20EPINEX%20DIAGNOSTICS%20INC%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=EPINEX%20DIAGNOSTICS%20INC&page=%2Fdata%2Fform-d%2Fcompany%2Fepinex-diagnostics-inc-1309623)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in California](https://specstream.ai/data/form-d/state/california): 5,891 rows, by operating companies, filed since November 1, 2024, $138.91, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/california
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 14351 MYFORD ROAD, UNIT J, Tustin, CA, 92780
- Phone: (949) 660-7770
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: California
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1309623

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Feb 10, 2016 | New notice | $100,000 | $100,000 | $0 | 1 | Jan 29, 2016 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1309623/000107704816000084/0001077048-16-000084-index.htm) |
| Jan 15, 2016 | Amendment | $3,000,000 | $2,170,092 | $829,908 | 72 | Feb 19, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1309623/000107704816000081/0001077048-16-000081-index.htm) |
| May 20, 2014 | New notice | $1,000,000 | $200,000 | $800,000 | 2 | May 13, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1309623/000107704814000120/0001077048-14-000120-index.htm) |
| Aug 2, 2013 | Amendment | $1,668,168 | $318,000 | $1,350,168 | 13 | Feb 19, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1309623/000107704813000108/0001077048-13-000108-index.htm) |
| Mar 5, 2013 | New notice | $1,668,168 | $318,000 | $1,350,168 | 13 | Feb 19, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1309623/000107704813000041/0001077048-13-000041-index.htm) |
| Mar 14, 2012 | New notice | $5,000,000 | $50,000 | $4,950,000 | 2 | Mar 1, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1309623/000107704812000120/0001077048-12-000120-index.htm) |
| Apr 28, 2011 | New notice | $3,000,000 | $202,756 | $2,797,244 | 9 | Apr 15, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1309623/000107704811000110/0001077048-11-000110-index.htm) |
| Aug 10, 2010 | New notice | $2,040,000 | $598,740 | $1,441,260 | 27 | Jul 26, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1309623/000107704810000075/0001077048-10-000075-index.htm) |
| Nov 13, 2009 | Amendment | $15,015,000 | $1,174,857 | $13,840,143 | 41 | Apr 17, 2008 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1309623/000130962309000008/0001309623-09-000008-index.htm) |
| Nov 3, 2009 | Amendment | $15,015,000 | $1,164,857 | $13,850,143 | 40 | Apr 17, 2008 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1309623/000130962309000006/0001309623-09-000006-index.htm) |
| Jul 15, 2009 | Amendment | $15,015,000 | $1,119,857 | $13,895,143 | 38 | Apr 17, 2008 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1309623/000130962309000005/0001309623-09-000005-index.htm) |
| Jun 12, 2009 | Amendment | $15,015,000 | $1,074,257 | $13,940,743 | 35 | Apr 17, 2008 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1309623/000130962309000004/0001309623-09-000004-index.htm) |
| Apr 21, 2009 | Amendment | $15,015,000 | $1,019,017 | $13,995,983 | 33 | Apr 17, 2008 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1309623/000130962309000003/0001309623-09-000003-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Asad Zaidi | Executive Officer, Director |  |
| Azra Zaidi | Director |  |
| Henry Smith | Executive Officer, Director |  |

## Other biotechnology companies in California that filed recently

- [CARI Health, Inc.](https://specstream.ai/data/form-d/company/cari-health-inc-1930994) $280,000 · Nov 6, 2026
- [Ausel, Inc.](https://specstream.ai/data/form-d/company/ausel-inc-2124022) $120,000 · Nov 4, 2026
- [Trellis Bioscience, Inc.](https://specstream.ai/data/form-d/company/trellis-bioscience-inc-1162015) $9.1 million · Oct 29, 2026
- [BigHat Biosciences, Inc.](https://specstream.ai/data/form-d/company/bighat-biosciences-inc-1797256) $75.1 million · Oct 26, 2026
- [Theravie Pharma, Inc.](https://specstream.ai/data/form-d/company/theravie-pharma-inc-2160768) $750,000 · Oct 19, 2026
- [Adela, Inc.](https://specstream.ai/data/form-d/company/adela-inc-1852167) $12 million · Oct 19, 2026
- [Estuary Biotherapeutics, Inc.](https://specstream.ai/data/form-d/company/estuary-biotherapeutics-inc-2138862) $40.7 million · Oct 16, 2026
- [Renue Life Sciences, Inc.](https://specstream.ai/data/form-d/company/renue-life-sciences-inc-2158207) $250,000 · Oct 14, 2026
- [Tempest Therapeutics, Inc.](https://specstream.ai/data/form-d/company/tempest-therapeutics-inc-1544227) $7.5 million · Oct 14, 2026
- [Lionheart Health, Inc.](https://specstream.ai/data/form-d/company/lionheart-health-inc-2156758) $387,500 · Oct 7, 2026
- [Rakuten Medical, Inc.](https://specstream.ai/data/form-d/company/rakuten-medical-inc-1595215) $9 million · Oct 6, 2026
- [Zonaliz, Inc.](https://specstream.ai/data/form-d/company/zonaliz-inc-2157556) $2.5 million · Oct 5, 2026
- [Altay Therapeutics, Inc.](https://specstream.ai/data/form-d/company/altay-therapeutics-inc-2157551) $15.7 million · Oct 2, 2026
- [Sialia Therapeutics, Inc.](https://specstream.ai/data/form-d/company/sialia-therapeutics-inc-2156754) $1.5 million · Sep 29, 2026
- [Vetmab Biosciences, Inc.](https://specstream.ai/data/form-d/company/vetmab-biosciences-inc-1932050) $11.4 million · Sep 29, 2026

[Every Form D from the week of Feb 8, 2016](https://specstream.ai/data/form-d/week/2016-02-08) · [All recent filings in California](https://specstream.ai/data/form-d/state/california) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what EPINEX DIAGNOSTICS INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).